Women’s preferences for vaginal antimicrobial contraceptives IV: Attributes of a formulation that would protect from STD/AIDS
Vaginal formulations may have “dual” protective activity, against sexually transmitted diseases/AIDS and unplanned pregnancy. The attributes that women find acceptable or unacceptable for such dual protective methods were investigated. More than 50% of the women would not accept messiness, but it wa...
Gespeichert in:
Veröffentlicht in: | Contraception (Stoneham) 1998-10, Vol.58 (4), p.251-255 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 255 |
---|---|
container_issue | 4 |
container_start_page | 251 |
container_title | Contraception (Stoneham) |
container_volume | 58 |
creator | Hardy, Ellen de Pádua, Karla S Osis, Maria José D Jiménez, Ana Luisa Zaneveld, Lourens J.D |
description | Vaginal formulations may have “dual” protective activity, against sexually transmitted diseases/AIDS and unplanned pregnancy. The attributes that women find acceptable or unacceptable for such dual protective methods were investigated. More than 50% of the women would not accept messiness, but it was more accepted for dual protective methods than for contraceptives. Very few women would use a dual protective method if it caused vaginal irritation, itching, swelling, or burning, problems associated with presently marketed methods. More than half of the women would use it if it appeared on the penis of their partner or required refrigeration. Use of an applicator to insert the formulation was generally preferred over a manual method. Most women preferred the formulation to be colorless or white, about 16% liked light colors, and about 10% liked darker colors. Almost half of the women were willing to pay up to $5.00 per application of a dual protective formulation, about 15% $3.00, and 30% $1.00. Dual protective methods seem highly acceptable and women would pay much more for them than for condoms. However, these methods should be free of problems usually associated with presently marketed formulations. |
doi_str_mv | 10.1016/S0010-7824(98)00106-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69101044</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0010782498001061</els_id><sourcerecordid>69101044</sourcerecordid><originalsourceid>FETCH-LOGICAL-e291t-a6d44c3d12888af350c3c50c34f41d5e6f78238ef72a15ab4a6697630754f2533</originalsourceid><addsrcrecordid>eNo9kc9u1DAQxi0EKkvhESr5gBAcQsex4zhc0Krlz0qVOGyBozXr2GCUxFvbWcQJXoPX40lw2lUvtj7NzzOe7yPkjMFrBkyebwEYVK2qxctOvVqErNgDsmKq7SpomHpIVvfIY_IkpR8A0HZNe0JOOiUlgFqR31_DaKd_f_4muo_W2WgnYxN1IdIDfvMTDhSn7EdvYtj5okyYckRj99kfCrj58oauc45-N-cig6O4PB7nAbMPE83fMdOfYR760j9kazJ1MYx0e315vt5cbp-SRw6HZJ8d71Py-f2764uP1dWnD5uL9VVl647lCmUvhOE9q5VS6HgDhpvlEE6wvrHSlS25sq6tkTW4Eyhl10oObSNc3XB-Sl7c9S2_uJltynr0ydhhwMmGOWnZFVNBiAKeHcF5N9pe76MfMf7SR8dK_fmxjsng4CJOxqd7jElgHKBgb-8wW5Y6eBt1Mn7xtvexmKD74DUDvSSpb5PUS0xlir5NUjP-H5pYkLw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69101044</pqid></control><display><type>article</type><title>Women’s preferences for vaginal antimicrobial contraceptives IV: Attributes of a formulation that would protect from STD/AIDS</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Hardy, Ellen ; de Pádua, Karla S ; Osis, Maria José D ; Jiménez, Ana Luisa ; Zaneveld, Lourens J.D</creator><creatorcontrib>Hardy, Ellen ; de Pádua, Karla S ; Osis, Maria José D ; Jiménez, Ana Luisa ; Zaneveld, Lourens J.D</creatorcontrib><description>Vaginal formulations may have “dual” protective activity, against sexually transmitted diseases/AIDS and unplanned pregnancy. The attributes that women find acceptable or unacceptable for such dual protective methods were investigated. More than 50% of the women would not accept messiness, but it was more accepted for dual protective methods than for contraceptives. Very few women would use a dual protective method if it caused vaginal irritation, itching, swelling, or burning, problems associated with presently marketed methods. More than half of the women would use it if it appeared on the penis of their partner or required refrigeration. Use of an applicator to insert the formulation was generally preferred over a manual method. Most women preferred the formulation to be colorless or white, about 16% liked light colors, and about 10% liked darker colors. Almost half of the women were willing to pay up to $5.00 per application of a dual protective formulation, about 15% $3.00, and 30% $1.00. Dual protective methods seem highly acceptable and women would pay much more for them than for condoms. However, these methods should be free of problems usually associated with presently marketed formulations.</description><identifier>ISSN: 0010-7824</identifier><identifier>EISSN: 1879-0518</identifier><identifier>DOI: 10.1016/S0010-7824(98)00106-1</identifier><identifier>PMID: 9866008</identifier><identifier>CODEN: CCPTAY</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Acquired Immunodeficiency Syndrome - prevention & control ; Adolescent ; Adult ; AIDS ; AIDS/HIV ; Anti-Infective Agents - administration & dosage ; Biological and medical sciences ; Birth control ; Brazil ; Color ; Consumer Behavior ; contraception ; Contraceptive Agents, Female - administration & dosage ; contraceptive usage ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Medical sciences ; Middle Aged ; Odorants ; Other methods of contraception. Sterilization ; Pregnancy ; sexually transmitted diseases ; Sexually Transmitted Diseases - prevention & control ; Socioeconomic Factors ; Vaginal Creams, Foams, and Jellies ; vaginal formulation</subject><ispartof>Contraception (Stoneham), 1998-10, Vol.58 (4), p.251-255</ispartof><rights>1998 Elsevier Science Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0010782498001061$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1601300$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9866008$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hardy, Ellen</creatorcontrib><creatorcontrib>de Pádua, Karla S</creatorcontrib><creatorcontrib>Osis, Maria José D</creatorcontrib><creatorcontrib>Jiménez, Ana Luisa</creatorcontrib><creatorcontrib>Zaneveld, Lourens J.D</creatorcontrib><title>Women’s preferences for vaginal antimicrobial contraceptives IV: Attributes of a formulation that would protect from STD/AIDS</title><title>Contraception (Stoneham)</title><addtitle>Contraception</addtitle><description>Vaginal formulations may have “dual” protective activity, against sexually transmitted diseases/AIDS and unplanned pregnancy. The attributes that women find acceptable or unacceptable for such dual protective methods were investigated. More than 50% of the women would not accept messiness, but it was more accepted for dual protective methods than for contraceptives. Very few women would use a dual protective method if it caused vaginal irritation, itching, swelling, or burning, problems associated with presently marketed methods. More than half of the women would use it if it appeared on the penis of their partner or required refrigeration. Use of an applicator to insert the formulation was generally preferred over a manual method. Most women preferred the formulation to be colorless or white, about 16% liked light colors, and about 10% liked darker colors. Almost half of the women were willing to pay up to $5.00 per application of a dual protective formulation, about 15% $3.00, and 30% $1.00. Dual protective methods seem highly acceptable and women would pay much more for them than for condoms. However, these methods should be free of problems usually associated with presently marketed formulations.</description><subject>Acquired Immunodeficiency Syndrome - prevention & control</subject><subject>Adolescent</subject><subject>Adult</subject><subject>AIDS</subject><subject>AIDS/HIV</subject><subject>Anti-Infective Agents - administration & dosage</subject><subject>Biological and medical sciences</subject><subject>Birth control</subject><subject>Brazil</subject><subject>Color</subject><subject>Consumer Behavior</subject><subject>contraception</subject><subject>Contraceptive Agents, Female - administration & dosage</subject><subject>contraceptive usage</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Odorants</subject><subject>Other methods of contraception. Sterilization</subject><subject>Pregnancy</subject><subject>sexually transmitted diseases</subject><subject>Sexually Transmitted Diseases - prevention & control</subject><subject>Socioeconomic Factors</subject><subject>Vaginal Creams, Foams, and Jellies</subject><subject>vaginal formulation</subject><issn>0010-7824</issn><issn>1879-0518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kc9u1DAQxi0EKkvhESr5gBAcQsex4zhc0Krlz0qVOGyBozXr2GCUxFvbWcQJXoPX40lw2lUvtj7NzzOe7yPkjMFrBkyebwEYVK2qxctOvVqErNgDsmKq7SpomHpIVvfIY_IkpR8A0HZNe0JOOiUlgFqR31_DaKd_f_4muo_W2WgnYxN1IdIDfvMTDhSn7EdvYtj5okyYckRj99kfCrj58oauc45-N-cig6O4PB7nAbMPE83fMdOfYR760j9kazJ1MYx0e315vt5cbp-SRw6HZJ8d71Py-f2764uP1dWnD5uL9VVl647lCmUvhOE9q5VS6HgDhpvlEE6wvrHSlS25sq6tkTW4Eyhl10oObSNc3XB-Sl7c9S2_uJltynr0ydhhwMmGOWnZFVNBiAKeHcF5N9pe76MfMf7SR8dK_fmxjsng4CJOxqd7jElgHKBgb-8wW5Y6eBt1Mn7xtvexmKD74DUDvSSpb5PUS0xlir5NUjP-H5pYkLw</recordid><startdate>19981001</startdate><enddate>19981001</enddate><creator>Hardy, Ellen</creator><creator>de Pádua, Karla S</creator><creator>Osis, Maria José D</creator><creator>Jiménez, Ana Luisa</creator><creator>Zaneveld, Lourens J.D</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19981001</creationdate><title>Women’s preferences for vaginal antimicrobial contraceptives IV: Attributes of a formulation that would protect from STD/AIDS</title><author>Hardy, Ellen ; de Pádua, Karla S ; Osis, Maria José D ; Jiménez, Ana Luisa ; Zaneveld, Lourens J.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e291t-a6d44c3d12888af350c3c50c34f41d5e6f78238ef72a15ab4a6697630754f2533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Acquired Immunodeficiency Syndrome - prevention & control</topic><topic>Adolescent</topic><topic>Adult</topic><topic>AIDS</topic><topic>AIDS/HIV</topic><topic>Anti-Infective Agents - administration & dosage</topic><topic>Biological and medical sciences</topic><topic>Birth control</topic><topic>Brazil</topic><topic>Color</topic><topic>Consumer Behavior</topic><topic>contraception</topic><topic>Contraceptive Agents, Female - administration & dosage</topic><topic>contraceptive usage</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Odorants</topic><topic>Other methods of contraception. Sterilization</topic><topic>Pregnancy</topic><topic>sexually transmitted diseases</topic><topic>Sexually Transmitted Diseases - prevention & control</topic><topic>Socioeconomic Factors</topic><topic>Vaginal Creams, Foams, and Jellies</topic><topic>vaginal formulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hardy, Ellen</creatorcontrib><creatorcontrib>de Pádua, Karla S</creatorcontrib><creatorcontrib>Osis, Maria José D</creatorcontrib><creatorcontrib>Jiménez, Ana Luisa</creatorcontrib><creatorcontrib>Zaneveld, Lourens J.D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Contraception (Stoneham)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hardy, Ellen</au><au>de Pádua, Karla S</au><au>Osis, Maria José D</au><au>Jiménez, Ana Luisa</au><au>Zaneveld, Lourens J.D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Women’s preferences for vaginal antimicrobial contraceptives IV: Attributes of a formulation that would protect from STD/AIDS</atitle><jtitle>Contraception (Stoneham)</jtitle><addtitle>Contraception</addtitle><date>1998-10-01</date><risdate>1998</risdate><volume>58</volume><issue>4</issue><spage>251</spage><epage>255</epage><pages>251-255</pages><issn>0010-7824</issn><eissn>1879-0518</eissn><coden>CCPTAY</coden><abstract>Vaginal formulations may have “dual” protective activity, against sexually transmitted diseases/AIDS and unplanned pregnancy. The attributes that women find acceptable or unacceptable for such dual protective methods were investigated. More than 50% of the women would not accept messiness, but it was more accepted for dual protective methods than for contraceptives. Very few women would use a dual protective method if it caused vaginal irritation, itching, swelling, or burning, problems associated with presently marketed methods. More than half of the women would use it if it appeared on the penis of their partner or required refrigeration. Use of an applicator to insert the formulation was generally preferred over a manual method. Most women preferred the formulation to be colorless or white, about 16% liked light colors, and about 10% liked darker colors. Almost half of the women were willing to pay up to $5.00 per application of a dual protective formulation, about 15% $3.00, and 30% $1.00. Dual protective methods seem highly acceptable and women would pay much more for them than for condoms. However, these methods should be free of problems usually associated with presently marketed formulations.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>9866008</pmid><doi>10.1016/S0010-7824(98)00106-1</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0010-7824 |
ispartof | Contraception (Stoneham), 1998-10, Vol.58 (4), p.251-255 |
issn | 0010-7824 1879-0518 |
language | eng |
recordid | cdi_proquest_miscellaneous_69101044 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Acquired Immunodeficiency Syndrome - prevention & control Adolescent Adult AIDS AIDS/HIV Anti-Infective Agents - administration & dosage Biological and medical sciences Birth control Brazil Color Consumer Behavior contraception Contraceptive Agents, Female - administration & dosage contraceptive usage Female Gynecology. Andrology. Obstetrics Humans Medical sciences Middle Aged Odorants Other methods of contraception. Sterilization Pregnancy sexually transmitted diseases Sexually Transmitted Diseases - prevention & control Socioeconomic Factors Vaginal Creams, Foams, and Jellies vaginal formulation |
title | Women’s preferences for vaginal antimicrobial contraceptives IV: Attributes of a formulation that would protect from STD/AIDS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T20%3A52%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Women%E2%80%99s%20preferences%20for%20vaginal%20antimicrobial%20contraceptives%20IV:%20Attributes%20of%20a%20formulation%20that%20would%20protect%20from%20STD/AIDS&rft.jtitle=Contraception%20(Stoneham)&rft.au=Hardy,%20Ellen&rft.date=1998-10-01&rft.volume=58&rft.issue=4&rft.spage=251&rft.epage=255&rft.pages=251-255&rft.issn=0010-7824&rft.eissn=1879-0518&rft.coden=CCPTAY&rft_id=info:doi/10.1016/S0010-7824(98)00106-1&rft_dat=%3Cproquest_pubme%3E69101044%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69101044&rft_id=info:pmid/9866008&rft_els_id=S0010782498001061&rfr_iscdi=true |